First Trust NYSE Arca Biotechnology Index Fund Rating $177.90 -0.07 (-0.04%) As of 02/21/2025 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatings First Trust NYSE Arca Biotechnology Index Fund Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.FBT Aggregate RatingModerate Buy 2.65Holdings in FBT have an aggregate rating of Moderate Buy based on 526 analyst ratings issued in the past year covering 29 companies (95.7% of the portfolio).FBT Aggregate Price Target$177.90High Prediction$177.90Average Prediction$177.90Low Prediction$177.90Holdings in FBT have an aggregate price target of $177.90 and a range of $177.90 to $177.90 covering 29 companies (95.7% of the portfolio).FBT Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy2 Buy rating(s)Moderate Buy21 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by First Trust NYSE Arca Biotechnology Index Fund Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 29 FBT Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings4.53%CORTCorcept Therapeutics$63.54-2.4%4.6892 of 5 stars3.00$88.25 38.9%5Upcoming Earnings4.46%ITCIIntra-Cellular Therapies$128.60+0.0%3.8947 of 5 stars2.53$103.62 -19.4%15Earnings ReportAnalyst ForecastNews Coverage3.78%ALKSAlkermes$35.33-0.5%3.6896 of 5 stars2.82$38.36 8.6%113.75%AMGNAmgen$303.01+1.7%4.4751 of 5 stars2.46$314.09 3.7%24Insider TradePositive News3.75%ALNYAlnylam Pharmaceuticals$250.59-0.2%4.4628 of 5 stars2.72$299.48 19.5%25Analyst ForecastInsider Trade3.69%VRTXVertex Pharmaceuticals$484.24+0.8%4.1184 of 5 stars2.65$505.61 4.4%26Analyst DowngradeInsider TradeAnalyst RevisionPositive News3.65%MTDMettler-Toledo International$1,285.67-1.3%3.9114 of 5 stars2.11$1,368.00 6.4%9Positive News3.60%HALOHalozyme Therapeutics$57.75+0.5%4.4627 of 5 stars2.60$62.78 8.7%10Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage3.55%GILDGilead Sciences$109.95-0.1%4.7947 of 5 stars2.72$102.08 -7.2%29Analyst UpgradeInsider TradeOptions VolumeAnalyst RevisionPositive News3.55%ACADACADIA Pharmaceuticals$19.95-1.7%3.0693 of 5 stars2.53$24.00 20.3%17Upcoming EarningsShort Interest ↓3.54%WATWaters$374.24-1.7%3.9937 of 5 stars2.44$390.40 4.3%163.27%VCYTVeracyte$39.18-4.6%2.9086 of 5 stars2.67$42.00 7.2%9Analyst DowngradeNews Coverage3.22%ARGXargenx$644.48-0.5%2.5007 of 5 stars2.86$658.39 2.2%22News CoveragePositive News3.22%NTRANatera$162.31-3.5%2.5723 of 5 stars3.00$170.94 5.3%16Positive News3.21%UTHRUnited Therapeutics$361.10-1.7%4.3818 of 5 stars2.67$388.25 7.5%12Insider TradePositive News3.20%RGENRepligen$158.99-2.3%4.4474 of 5 stars2.62$181.00 13.8%13Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage3.17%REGNRegeneron Pharmaceuticals$700.33+0.6%4.6674 of 5 stars2.76$973.13 39.0%25Dividend Announcement3.13%BMRNBioMarin Pharmaceutical$68.25-0.7%4.9188 of 5 stars2.70$93.81 37.4%23Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage3.12%INCYIncyte$72.05+0.9%4.541 of 5 stars2.35$75.59 4.9%203.11%BIIBBiogen$140.64+2.6%4.7515 of 5 stars2.43$211.85 50.6%30Analyst Forecast3.09%BNTXBioNTech$120.01+1.8%2.39 of 5 stars2.88$142.72 18.9%17Positive NewsHigh Trading Volume3.02%EXELExelixis$36.85+5.0%4.5093 of 5 stars2.55$37.24 1.0%20Analyst UpgradeInsider Trade3.00%EXASExact Sciences$49.26-0.5%4.6972 of 5 stars2.95$72.06 46.3%19Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage2.92%SRPTSarepta Therapeutics$106.28-2.0%4.5118 of 5 stars2.87$176.77 66.3%23Upcoming Earnings2.83%GMABGenmab A/S$22.34-0.4%4.5963 of 5 stars2.75$42.17 88.7%122.76%BRKRBruker$50.82-4.0%4.8618 of 5 stars2.55$70.50 38.7%112.75%NBIXNeurocrine Biosciences$120.69+3.9%4.9825 of 5 stars2.83$166.90 38.3%23Analyst DowngradeBuyback AnnouncementAnalyst RevisionGap Up2.44%ILMNIllumina$94.20-3.1%4.7855 of 5 stars2.62$159.45 69.3%212.43%MRNAModerna$35.53+5.3%4.7405 of 5 stars2.04$60.63 70.6%23Analyst DowngradeOptions Volume This page (NYSEARCA:FBT) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredThe Real Hillbilly ElegyThe mountains of Appalachia are incredible to behold. Spanning thousands of miles across Alabama, Kentucky...Porter & Company | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding First Trust NYSE Arca Biotechnology Index Fund Please log in to your account or sign up in order to add this asset to your watchlist. Share First Trust NYSE Arca Biotechnology Index Fund With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
